Development and validation of a clinical model to predict medication adherence among chronic kidney disease patients

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200062288

Enrollment

Unknown

Registered

2022-07-31

Start date

2022-07-17

Completion date

Unknown

Last updated

2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic kidney disease (CKD)

Interventions

case series:None

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 18 and 80 years. 2. Meeting the diagnostic criteria for chronic kidney disease in the KDOQI Clinical Practice Guidelines for the Evaluation and Management of Chronic Kidney Disease, with CKD stage 1 to 5 non-dialysis stage. 3. Receiving drug therapy (continuous medication duration >= 3 months). 4. Those who are informed and sign the informed consent form.

Exclusion criteria

Exclusion criteria: Those with cognitive, visual, or hearing impairments and those with mental illness.

Design outcomes

Primary

Measure	Time frame
Morisky Medication Adherence Scale, MMAS-4;Kidney Disease Quality of Life, KDQOL-36TM;	—

Secondary

Measure	Time frame
Questionnaire on Influencing Factors of Medication Adherence;Medication knowledge;Beliefs about Medicine Questionnaire, BMQ-specific;Resilience Scale;Family Caring Index Scale (APGAR);Acceptance Illness Scale, AIS;Grip strength;Modified Quantitative Subjective Global Assessment, MQSGA;Chinese Medicine Constitution Questionnaire;Kessler 10, K-10;Nonrestorative sleep;	—

Countries

China

Contacts

Public ContactYe Zengjie, Deng Lili

zengjieye@qq.com+86 15914411786

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 11, 2026